Phase 2 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand the study and are willing to sign a written consent form
- People aged 2 to 70 years old
- People who have a brain tumor that has come back or has not responded to treatment, with tumors that can be measured on scans, and who have already received standard treatment such as surgery and radiation/chemotherapy; at the time of a white blood cell collection procedure, the person must either not be taking dexamethasone (a steroid) or be taking no more than 4 mg per day
- People with a performance score showing they can carry out basic daily activities (Karnofsky score of 60 or above — confirm with trial site if unsure what this means)
- People with a life expectancy of more than 3 months
- People whose bone marrow, liver, and kidney are functioning at levels that meet the trial's required blood test results (the trial site can confirm whether specific results meet these levels)
- People with a lymphocyte count (a type of white blood cell) above a certain level, as confirmed by a blood test
- People with satisfactory heart function
- People who are willing to follow the medical team's instructions throughout the study
- Women of reproductive age (15–49 years old) who have a negative pregnancy test within 7 days of starting the study; people of reproductive potential must agree to use contraception during the study and for 3 months after it ends
Who may not be able to join:
- People who have had a Gliadel wafer implant (a type of chemotherapy implant placed in the brain during surgery) within 4 weeks before the study starts, or who are currently receiving antibody-based treatments
- People who are HIV positive
- People who have tuberculosis that is not under control
- People with a history of autoimmune disease, or any condition that requires long-term use of steroids or immune-suppressing medications
- People with a history of allergic disease, or a known allergy to immune cells or the ingredients used in the study treatment
- People who are already actively taking part in another clinical trial involving immune cell therapy, or people who the trial investigators believe may not be suitable or able to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with adverse events.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.